Despite some inconsistent results, a few studies have reported that among patients with alcohol use disorders treated with naltrexone, those carrying the OPRM1 A118G variant had a lower relapse rate than those carrying the OPRM1 A118A variant [54,55]. This evidence concerns the gene OPRM1 and alcohol abuse.